ASH HIGHLIGHTS 2024 – LEUKEMIA ROUNDTABLE DISCUSSIONS: Venetoclax Combined with “7+3” Induction Chemotherapy Induces High MRD-Negative Response Rates
OR
Explore more from your favourite experts – click their name to access their entire library of content.
Chair
